UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 861177
NEW YORK, NY
Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,127,579
+$1,803,721 QoQ
Shares Held
107,094
-0.3% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 341 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. PTGX ranks #35 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,127,579 | 107,094 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $11,323,858 | 107,437 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,129,471 | 104,528 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,322,508 | 110,229 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,451,220 | 243,373 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,095,436 | 208,756 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $11,113,361 | 287,911 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,565,940 | 368,132 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,818,936 | 369,955 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,700,746 | 335,318 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,628,576 | 289,079 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,185,262 | 71,059 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,789,165 | 64,778 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,489,894 | 64,778 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $229,927 | 27,275 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $258,371 | 32,664 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $773,482 | 32,664 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,117,108 | 32,664 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $489,035 | 27,598 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,238,598 | 27,598 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $647,500 | 25,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $245,952 | 12,200 | Shares | Sole | 2021-03-01 | |
| No filing history on record for this holder in this stock. | ||||||